Federal health advisers on Tuesday voted in favor of an experimental drug from InterMune Inc., despite mixed evidence of whether it provides significant benefits for patients with a rare lung disease. The Food and Drug Administration's panel of lung experts voted 9-3 to recommend approval of ...

WASHINGTON (Reuters) - Comparing medical treatments to find the best and the cheapest may be a pillar of U.S. healthcare reform efforts, but very little such research is being done, according to a report published on Tuesday. Most of the so-called comparative effectiveness research is done at academic institutions or by other noncommercial enterprises, and less than 20 percent examine ...

CHICAGO (Reuters) - Inoculating children against flu protects more people of all ages in the larger community, probably because young people tend to spread viruses through physical play, Canadian researchers said on Tuesday. Researchers at McMaster University in Hamilton, Ontario found there were 61 percent fewer flu cases in isolated communities where children and adolescents received the seasonal influenza vaccine, compared ...